Homocysteine (HCy) is an intermediate amino acid formed during the metabolism of methionine to cysteine. In the recent years, it has emerged as a risk factor for cardiovascular disease independent of known other factors (1) (2) (3) . The first methods developed for total plasma HCy measurements were HPLC, with or without derivatization, and gas chromatography. Later, immunoassays were developed, allowing automation and widespread use of the marker in the medical world. Plasma HCy is influenced by various factors: genetics, diet, sex, age, ethnic group, drugs, and diseases. EDTA-, citrate-, or heparin-anticoagulated blood may be used, but plasma should be immediately separated from blood cells to avoid spurious increases (4 ) . Addition of different substances has been suggested to reduce these spurious increases in HCy concentrations. Acidic citrate has been shown to be effective in some studies (5 ) but not in others (6 ) . A specific inhibitor of S-adenosylhomocysteine hydrolase (3-deaza-adenosine) was successfully used, but unfortunately, it is not compatible with immunoassays (7 ) . Fluoride appears to be the most interesting additive. Ubbink et al. (8 ) showed that it prevents in vitro increases for 2 h. Several studies have confirmed this effect (9 ), although others have not (10 ) . In most studies, plasma HCy from blood collected in fluoride tubes has been lower than in EDTA tubes (10 -12 ) .
Our aim was to evaluate the protective effect of fluoride against spurious increases of in vitro HCy and to establish reference intervals for the AxSYM immunoassay (Abbott) for plasma HCy from blood collected into fluoride tubes.
The HCy assay was performed on the AxSYM analyzer according to the manufacturer's instructions. Folic acid and vitamin B 12 measurements were performed on the Elecsys analyzer (Roche Diagnostics) according to the manufacturer's instructions.
For the study of a possible fluoride protective effect, blood was drawn from 22 individuals and collected in EDTA and fluoride-oxalate tubes (Terumo). Fluorideoxalate tubes contained 6.75 mg of lyophilized sodium fluoride (54 mmol/L of blood). Plasma was separated immediately (centrifugation started within 2 min) and after 1, 2, and 5 h at room temperature. The HCy assay was performed on each aliquot. Two hundred and thirty women (mean age, 41 years; range, 24 -59 years) and 126 men (mean age, 42 years; range, 23-63 years) who are workers in Erasme Hospital (Brussels) were included in the reference interval and vitamin correlation studies. The study was approved by the local ethics committee. For the establishment of plasma HCy reference values, fasting venous blood was drawn in fluoride-oxalate tubes transported on crushed ice to the laboratory, where plasma was immediately separated from blood cells and analyzed within 2 h. For vitamin B 12 and folic acid measurements, serum was analyzed within 4 h after collection. Statistical analyses were performed with Analyze-It for Microsoft Table 1 are the mean HCy concentrations obtained for 22 individuals whose blood was collected in tubes containing either EDTA or fluoride-oxalate. After 1 h at room temperature before separation of plasma from red blood cells, HCy increased by 8.5% in EDTA tubes but by 2.5% in fluoride tubes. After 2 h, the changes were 21.1% in EDTA tubes and 6.5% in fluoride tubes, and after 5 h, they were 39.9% and 14.8%. Results obtained for samples collected in EDTA tubes were systematically higher than for samples collected in fluoride-oxalate tubes. Even when plasma was separated immediately after blood collection, concentrations showed a 8.7% difference (P Ͻ10 Ϫ6 , paired Student t-test). Shown in Fig. 1 Hyperhomocysteinemia is a well-documented cardiovascular risk factor (1-3 ) . Because folic acid and vitamin B 12 supplementation can return plasma HCy concentrations to values within the reference intervals (13, 14 ) , accurate measurement of this analyte is desired. Preanalytical factors are important. It has been shown that HCy concentrations increase by ϳ10% per hour in unseparated whole blood, whereas at 0°C, no significant increase in HCy occurs during the first hour (4, 11 ) . Nevertheless, in a recent French study, only 16% of samples with HCy requested arrived at the laboratory within 1 h, and 28% of samples arrived at room temperature (15 ) , showing a potential useful role for a preservative agent such as fluoride. Although several authors have described the protective effect of this additive (8, 9 ) , in a recent study (16 ) , plasma HCy increased by 9% after 1 h and 24% after 4 h in whole blood samples collected in EDTA tubes and stored at room temperature. In fluoride tubes, similar increases of 8 -24% were observed. Hughes et al. (10 ) even suggested that the protective effect was only apparent. Our results did not confirm these data. In similar conditions, for fluoride tubes, we observed increases of 2.5% after 1 h, 6.5% after 2 h, and 14.8% after 5 h, whereas in EDTA tubes, we observed increases of 8.5% after 1 h, 21.1% after 2 h, and 40% after 5 h. This suggests that fluoride can be an essential additive, especially when plasma separation cannot be achieved quickly or when samples have not been kept at 0°C. Like others, we found lower HCy concentrations in fluoride tubes than in EDTA tubes. Although some authors believe that these lower concentrations are caused by dilution of plasma as a result of dehydration of red cells in the presence of fluoride (10 ), our data showing a much lower rate of increase in fluoride tubes compared with EDTA tubes suggest that this is truly a protective effect of fluoride. Age, sex, vitamin B 12 , and especially folic acid status are known to be determinants of plasma HCy concentrations (1, 3, 16 ) . Our results were in accordance with the literature. There was a statistically significant negative correlation between serum folate and plasma HCy and between serum vitamin B 12 and plasma HCy, but the correlation between age and HCy did not reach statistical significance. We found significantly higher HCy concentrations in men than in women (medians, 9.8 vs 8.3 mol/L) and reference values (4.7-16.3 mol/L) similar to, although slightly higher than, those commonly recommended (5-15 mol/L) (1, 16 ) .
This study was financed in part by Abbott Diagnostics Belgium (Louvain-La-Neuve, Belgium). Although hypocholesterolemia in posttraumatic states is considered a generic expression of acute-phase response, a relationship between severity of hypocholesterolemia and bad prognosis has also been found (1) (2) (3) (4) (5) (6) . The issue is still poorly understood and is complicated by the circumstance that plasma cholesterol is affected simultaneously by multiple factors whose impacts have never been distinctly characterized. The postoperative state after hepatectomy is an interesting condition in which most of these factors may be simultaneously present. We have assessed in detail the main biochemical and clinical correlates of hypocholesterolemia in a large group of patients undergoing hepatectomy.
Characterization of Biochemical and Clinical
Hepatectomies were performed in 92 patients (47 women, 45 men). The mean (Ϯ SD) age was 57 Ϯ 12 years, body weight was 70 Ϯ 11 kg, the ratio of actual to ideal body weight was 1.13 Ϯ 0.16 (1983 Metropolitan Tables), body surface area was 1.78 Ϯ 0.15 m 2 , and body mass index (weight/height 2 ) was 25.0 Ϯ 4.0 kg/m 2 . Thirty-six patients had primary liver malignancy (23 with hepatocarcinoma, 10 with cholangiocarcinoma, 3 with other neoplasms), 35 had secondary hepatic malignancies (23 from colorectal cancer, 12 from other sources), and 21 had benign lesions. Eighteen patients had liver cirrhosis. Fiftyfour patients were in ASA class I (7 ), 7 in class II, 30 in class III, and 1 in class IV. No patient was on cholesterollowering medication. Hepatectomies consisted of 43 minor (Ͻ3 liver segments) and 49 major resections (3-6 segments). The mean number of resected segments was 3 Ϯ 1. There were 17 associated bowel operations (resections for primary malignancy or Roux-en-Y biliary reconstructions). The duration of the operations was 390 Ϯ 149 min, and the duration of normothermic liver ischemia (used in 61 patients) was 49 Ϯ 28 min.
Seventy-one patients recovered without complications, whereas 15 had nonlethal complications: 9 had intraabdominal or pulmonary sepsis, 5 had transient liver insufficiency, and 1 had a biliary fistula without sepsis. Diagnosis of sepsis was based on previously defined criteria (5 ) . Six patients died. The study was carried out prospectively except for the inclusion of three nonsurvivors observed outside the prospective period; this improved the significance of results in nonsurvivors without bias because the pattern of death was similar in all cases (systemic sepsis with liver and/or respiratory insufficiency, progressing to multiple organ dysfunction syndrome). This patient population provided a continuous distribution of observations from minor to extreme surgical procedures (and degrees of postoperative illness) suited to assess correlates of hypocholesterolemia over a wide range of pathophysiologic abnormalities.
The database included 478 venous blood measurements. These were performed according to the clinical routine, without the need for consent, preoperatively and on postoperative days 1, 3, and 7 in all patients and thereafter only in those with complications until recovery or death. The following variables were considered: plasma cholesterol concentration, albumin, total protein, fibrinogen, creatinine, urate, alkaline phosphatase, ␥-glutamyltranspeptidase, total and indirect bilirubin, prothrombin activity, hematocrit, hemoglobin, blood cell counts, number of resected liver segments, duration of the operation and of eventual liver ischemia, occurrence of cirrhosis, neoplastic disease, previous chemotherapy, associated bowel operations, sepsis, cholestasis, and substrate doses in patients on parenteral nutrition. Statistical analysis was based on least-squares regressions and "best fit" procedures selecting the simplest possible regressions controlling the largest possible variability of cholesterol, based on Mallows' Cp criteria (8 ) .
Plasma cholesterol decreased on postoperative days 1 
